In polycystic ovary syndrome (PCOS) patients, follicular fluid EVs are enriched in S100-A9, which promotes inflammation and disrupts steroidogenesis by activating the NF-κB pathway, thereby impairing granulosa cell function (Li et al., 2020). The gene discussed is S100A9; the disease is polycystic ovary syndrome.